ImmunityBio
IBRX
$6.42
Share price
-2.87%
Change (1 day)
118.37%
Change (1 year)
Categories
Operating Margin for ImmunityBio (IBRX)
Operating Margin as of June 2024 (TTM): -147,405.00%
According to ImmunityBio's latest financial reports and stock price the company's current Operating Margin is -147,405.00%. At the end of 2021 the company had an Operating Margin of -37,456.00%.
Operating Margin history for ImmunityBio from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -37,456.00% | 0.25% |
| 2020 | -37,360.83% | 413.33% |
| 2019 | -7,278.07% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.